Bjork Elisabeth 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Oct 29, 2024
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-26+607→ 607 totalExercise: $17.60Exp: 2034-09-26→ Common Stock (607 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 607 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025.